Fusion Antibody Share News (FAB)

LONDON MARKET OPEN: Sluggish open ahead of US Fed testimony this week

(Alliance News) - London's equities got off to a slow start on Monday, lagging behind more positive trading in Europe and Friday's rally on Wall Street.

Fusion Antibodies launches first commercial service from OptiMAL

(Alliance News) - Fusion Antibodies PLC on Thursday celebrated the launch of a new commercial service from its research and development programme, designed to address mammalian cell surface expression.

Fusion Antibodies confident after 'challenging' first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenues of £1.9m on Monday, down from £2.4m year-on-year.

Fusion Antibodies half-year loss doubles amid investment delays

(Alliance News) - Fusion Antibodies PLC on Monday said its loss has widened and revenue is down, after the first half of the financial year proved a "challenging period".

UK earnings, trading statements calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Fusion Antibodies sees revenue growth on transient expression service

(Alliance News) - Fusion Antibodies PLC on Tuesday said it achieved full-year revenue ahead of expectations, due to its transient expression service.

IN BRIEF: Fusion Antibodies shares rise on patent application

Fusion Antibodies PLC - Belfast-based antibody developer - Submits patent application for its bispecific designs for antigen display. The designs include an antigen part, and a "reporter" part, called a "bispecific". Believes the reporter part will increase the rate of success in the identification of highly potent antibodies from its range of Antibody Discovery technologies.

EXECUTIVE CHANGES: Cohort co-founder out; Nuformix co-founder back

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

Fusion Antibodies reports strong full-year revenue growth

(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies reported 14% growth in revenue in a trading update on Friday, to £4.8m.

Fusion Antibodies annual revenue grows despite challenges

(Alliance News) - Fusion Antibodies PLC on Friday said it expects to post double-digit growth in revenue, leading to strong expectations for the current period.

TRADING UPDATES: Panther Securities wins lease; NightCap opens new bar

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

IN BRIEF: Fusion Antibodies sees no reason for share price fall

IN BRIEF: Fusion Antibodies sees no reason for share price fall

Fusion Antibodies forms new scientific advisory panel

(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies announced the formation of a new scientific advisory panel (SAP) of experts on Friday, to support research and development across its range of antibody services, and to provide advice regarding emerging science and technology issues and trends.

IN BRIEF: Fusion Antibodies loss widens on administrative expenses

IN BRIEF: Fusion Antibodies loss widens on administrative expenses